covid 19 News and Research

RSS

Longitudinal kinetics of the serological response in COVID-19 recovered patients over a period of 14 months

Researchers assessed the proportion of receptor-binding domain antibodies in COVID-19-recovered patients.

8 Jun 2022

More support needed for healthcare workers to stay mentally healthy during the pandemic

Health care workers in home care settings have played a crucial role in caring for vulnerable populations during the COVID-19 pandemic. But now, researchers from Japan have found that these workers need more support to stay mentally healthy.

8 Jun 2022

Researchers develop new chemical-only process for creating customized mRNA vaccines

Researchers at Nagoya University in Japan have developed a new chemical-only process that may represent an important breakthrough in creating customized mRNA vaccines for a variety of diseases and allow for the inexpensive preparation of mRNA in large quantities.

8 Jun 2022

Pregnant women's social contacts and COVID vaccination coverage in 19 European countries

In a recent study posted to the medRxiv* pre-print server, researchers from the London School of Hygiene and Tropical Medicine and Hasselt University surveyed the social contact patterns and coronavirus disease 2019 (COVID-19) vaccine uptake among women from 19 European countries pregnant between March 2020 and September 2021.

8 Jun 2022

Telemedicine facilitated the delivery of essential services for diabetes patients during the pandemic

A new study from the University of Eastern Finland indicates that the COVID-19 pandemic has seriously affected healthcare service usage among patients with 2 type diabetes in North Karelia, Finland, but essential care was continuously provided.

8 Jun 2022

Researchers plan to commence a clinical trial on new COVID-19 inactivated vaccine

A medical research team from the University of Hong Kong (HKU) will start a large-scale clinical trial on a new COVID-19 inactivated vaccine (Omicron variant) developed by China National Biotec Group (Sinopharm).

8 Jun 2022

Molnupiravir reduces hospitalizations and deaths in at-risk, unvaccinated adults with COVID

In a recent phase III study published in the New England Journal of Medicine, researchers demonstrated that oral molnupiravir was effective in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) therapy among non-vaccinated, non-hospitalized adults at-risk for severe illness.

8 Jun 2022

Research explores effects of iron status on risk of sepsis and severe COVID-19

In a recent article posted to the medRxiv* preprint server, investigators demonstrated a link between high iron status and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)- and sepsis-linked hospitalizations.

7 Jun 2022

OpenSAFELY study shows the effectiveness of Pfizer COVID booster doses

In a recent study posted to the medRxiv pre-print server, researchers assessed the effectiveness of the Pfizer–BioNTech BNT162b2 coronavirus disease 2019 (COVID-19) vaccine in the seven million United Kingdom (UK) adults who were eligible to receive booster shots between 16 September and 16 December 2021.

7 Jun 2022

Study finds added benefits of molnupiravir for non-hospitalized COVID-19 patients

In a recent investigation published in the Annals of Internal Medicine journal, scientists demonstrated the positive impacts of molnupiravir among severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) patients and the healthcare sector apart from lowering disease-linked deaths and hospitalizations in at-risk cohorts.

7 Jun 2022

Gastrointestinal complications caused by SARS-CoV-2

scientists discuss the gastrointestinal complications associated with COVID-19.

7 Jun 2022

How do viruses evolve to infect new hosts?

Researchers discuss how protein thermostability prevents the misfolding of viral proteins from being heated.

7 Jun 2022

Novel approach to drug repurposing incorporates two-stage prediction and machine learning

A new study presents a novel approach to drug repurposing that incorporates two-stage prediction and machine learning.

7 Jun 2022

People with HIV are at greater risk of breakthrough COVID-19 infections after vaccination

People with HIV have a higher rate of breakthrough COVID-19 infections after vaccination, compared to people without HIV, according to findings from a study led by researchers at the Johns Hopkins Bloomberg School of Public Health.

7 Jun 2022

Com-COV 3 study focuses on assessing a third dose booster vaccination for young people aged 12 to 15

The Com-COV 3 study has been commissioned through the NIHR and backed by £2.8 million government funding, with support from both the Vaccine Taskforce and National Institute for Health and Care Research (NIHR).

7 Jun 2022

COVID-19 vaccination may offer less effective and shorter-lasting protection for some cancer patients

A study co-led by the Universities of Oxford, Birmingham and Southampton and the UK Health Security Agency (UKHSA), published in Lancet Oncology today by the UK Coronavirus Cancer Evaluation Project, has found that while COVID-19 vaccination is effective in most cancer patients, the level of protection against COVID-19 infection, hospitalization and death offered by the vaccine is less than in the general population and vaccine effectiveness wanes more quickly.

7 Jun 2022

Molecular modeling techniques describe the process of interaction between nanotubes and the main structures of SARS-CoV-2

Researchers assessed the interactions between carbon nanotubes and SARS-CoV-2.

7 Jun 2022

covid 19 News and Research

Longitudinal kinetics of the serological response in COVID-19 recovered patients over a period of 14 months

More support needed for healthcare workers to stay mentally healthy during the pandemic

Researchers develop new chemical-only process for creating customized mRNA vaccines

Pregnant women's social contacts and COVID vaccination coverage in 19 European countries

Telemedicine facilitated the delivery of essential services for diabetes patients during the pandemic

Researchers plan to commence a clinical trial on new COVID-19 inactivated vaccine

Molnupiravir reduces hospitalizations and deaths in at-risk, unvaccinated adults with COVID

Research explores effects of iron status on risk of sepsis and severe COVID-19

OpenSAFELY study shows the effectiveness of Pfizer COVID booster doses

Study finds added benefits of molnupiravir for non-hospitalized COVID-19 patients

Gastrointestinal complications caused by SARS-CoV-2

How do viruses evolve to infect new hosts?

Novel approach to drug repurposing incorporates two-stage prediction and machine learning

People with HIV are at greater risk of breakthrough COVID-19 infections after vaccination

Com-COV 3 study focuses on assessing a third dose booster vaccination for young people aged 12 to 15

COVID-19 vaccination may offer less effective and shorter-lasting protection for some cancer patients

Molecular modeling techniques describe the process of interaction between nanotubes and the main structures of SARS-CoV-2

De novo-designed mini-protein against SARS-CoV-2

They thought they were buying Obamacare plans. What they got wasn’t insurance.

Influenza vaccination rates of health and aged care facility staff during the COVID-19 pandemic

Exploring the G:Box and for high-quality imaging

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Latest News